A multi-omics based anti-inflammatory immune signature characterizes long COVID-19 syndrome.
Kovarik, Johannes J, Bileck, Andrea, Hagn, Gerhard et al.·iScience·2023
Researchers compared blood samples from three groups: healthy people, people who recovered from COVID-19 without ongoing symptoms, and people with long COVID who have chronic fatigue and other persistent symptoms. They found that people with long COVID have lower levels of inflammation markers and higher levels of compounds that reduce inflammation, which is unexpected since many assumed long COVID involved high inflammation.